113 related articles for article (PubMed ID: 11934221)
1. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease.
Saller B; Görges R; Reinhardt W; Haupt K; Janssen OE; Mann K
Clin Lab; 2002; 48(3-4):191-200. PubMed ID: 11934221
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
Grauer A; Raue F; Ziegler R
Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
4. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
5. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer.
Trimboli P; Rossi F; Baldelli R; Laurenti O; Nigri G; Ventura C; Appetecchia M; Attanasio D; Romanelli F; Guidobaldi L; Guarino M; Crescenzi A; Valabrega S
Diagn Cytopathol; 2012 May; 40(5):394-8. PubMed ID: 21563324
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
[TBL] [Abstract][Full Text] [Related]
7. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
[TBL] [Abstract][Full Text] [Related]
8. Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada.
Daniels GH
Thyroid; 2011 Nov; 21(11):1199-207. PubMed ID: 21936671
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study.
Trimboli P; Cremonini N; Ceriani L; Saggiorato E; Guidobaldi L; Romanelli F; Ventura C; Laurenti O; Messuti I; Solaroli E; Madaio R; Bongiovanni M; Orlandi F; Crescenzi A; Valabrega S; Giovanella L
Clin Endocrinol (Oxf); 2014 Jan; 80(1):135-40. PubMed ID: 23627255
[TBL] [Abstract][Full Text] [Related]
10. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.
Bugalho MJ; Santos JR; Sobrinho L
J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359
[TBL] [Abstract][Full Text] [Related]
11. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin screening in patients with thyroid nodules. Diagnostic value.
Schneider C; Kobe C; Schmidt M; Kahraman D; Malchau G; Faust M; Schicha H; Dietlein M
Nuklearmedizin; 2012; 51(6):228-33. PubMed ID: 22940904
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
14. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.
Ghillani PP; Motté P; Troalen F; Jullienne A; Gardet P; Le Chevalier T; Rougier P; Schlumberger M; Bohuon C; Bellet D
Cancer Res; 1989 Dec; 49(23):6845-51. PubMed ID: 2555054
[TBL] [Abstract][Full Text] [Related]
15. Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay.
Verga U; Morpurgo PS; Vaghi I; Radetti G; Beck-Peccoz P
Horm Res; 2006; 66(1):17-20. PubMed ID: 16636574
[TBL] [Abstract][Full Text] [Related]
16. [Influence of the calcitonin assay on the definition of biochemical cure in patients with medullary thyroid carcinoma].
Hartung-Knemeyer V; Müller S; Nagarajah J; Lahner H; Broecker-Preuss M; Bockisch A; Görges R
Nuklearmedizin; 2012; 51(4):125-32. PubMed ID: 22526413
[TBL] [Abstract][Full Text] [Related]
17. Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test".
Niederle MB; Scheuba C; Gessl A; Li S; Koperek O; Bieglmayer C; Riss P; Selberherr A; Niederle B
Biochem Med (Zagreb); 2018 Oct; 28(3):030710. PubMed ID: 30429678
[TBL] [Abstract][Full Text] [Related]
18. The role of fine-needle aspiration biopsy in the management of patients with thyroid nodules.
Zagorianakou P; Malamou-Mitsi V; Zagorianakou N; Stefanou D; Tsatsoulis A; Agnantis NJ
In Vivo; 2005; 19(3):605-9. PubMed ID: 15875783
[TBL] [Abstract][Full Text] [Related]
19. Increased calcitonin level in thyroid nodules without medullary carcinoma.
Gibelin H; Essique D; Jones C; Levillain P; Maréchaud R; Kraimps JL
Br J Surg; 2005 May; 92(5):574-8. PubMed ID: 15779075
[TBL] [Abstract][Full Text] [Related]
20. The development of a two-site enzyme immunometric assay (EIA) for calcitonin and its application in the measurement of the hormone in normal subjects, MTC-patients and post-menopausal women.
Seth R; Motte P; Kehely A; Wimalawansa S; Self CH; Bohuon C; Bellet D; MacIntyre I
Horm Metab Res Suppl; 1989; 21():3-5. PubMed ID: 2680865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
